Step 1

Patentability Assessment (Optional but Recommended)

Before filing a patent application in India, it is essential to perform a patentability assessment to determine whether an invention is eligible for patent protection under the Indian Patents Act, 1970.

What is Patentability Assessment?

Patentability assessment is the process of evaluating an invention against the legal criteria for patent protection. It helps the inventor understand whether the invention is likely to be granted a patent and guides the drafting of a strong application.

Key Criteria for Patentability in India

To qualify for a patent, an invention must meet all of the following conditions:

1. Novelty (Section 2(1)(j))

• The invention must be new, meaning it has not been disclosed anywhere in the world before the filing date.
• No prior art (existing public knowledge or use) should contain the same invention.

Example: A new kind of biodegradable plastic not mentioned in any previous patent, journal, or product.

2. Inventive Step / Non-Obviousness (Section 2(1) (ja))

• The invention must involve a technical advancement or economic significance and must not be obvious to a person skilled in that technical field.
• It should not be a simple modification of existing technology.

Example: An improved water filtration system that increases efficiency using a unique membrane structure.

3. Industrial Applicability (Section 2(1)(ac))

• The invention must be capable of being made or used in an industry.
• Abstract ideas, theories, or scientific principles without practical application are not patentable.

Example: A new machine for extracting essential oils that can be used in the perfume industry.

4. Not Excluded under Sections 3 and 4

Some inventions are not patentable in India, even if they meet the above three criteria. These include:

• Section 3(d): Mere discovery of a new form of a known substance without enhanced efficacy.
• Section 3(e): A mere admixture resulting in the aggregation of properties.
• Section 3(i): Methods of treatment of humans or animals.
• Section 4: Inventions relating to atomic energy.

Example (Not Patentable): A new dosage form of a known medicine with no significant improvement in therapeutic effect.

Why Perform a Patentability Assessment?

• Saves time and cost by avoiding unpatentable filings.
• Helps prepare a stronger and more precise application.
• Identifies possible prior art to overcome during examination.
• Assists in drafting clear claims that enhance enforceability.

Tools for Patentability Search

• Indian Patent Database: ipindiaservices.gov.in
• Google Patents: https://patents.google.com
• WIPO Patentscope: https://patentscope.wipo.int

Step 2

Drafting the Patent Application

A patent application must be carefully drafted as it determines the scope of protection. It includes:

• Title of the invention
• Field of the invention
• Background and prior art
• Summary and detailed description
• Claims (legal boundaries of the invention)

Types of Patent Applications in India

Components of a Patent Application

Step 3

Filing the Patent Application

The patent application can be filed in any of the following ways:

• Physical Filing at the Patent Office (Mumbai, Delhi, Kolkata, Chennai).
• Online Filing via the Indian Patent Office e-filing system.

Forms Required for Filing:

Step 4

Publication of the Application

What is Patent Publication?

Patent publication is the official disclosure of a patent application by the Indian Patent Office (IPO). This step ensures transparency and allows third parties to assess whether the patent should be opposed.

• After filing, the application is published in the Patent Journal within 18 months.

Where is it published?

• The patent application is published in the Official Patent Journal on the Indian Patent Office website (ipindia.gov.in).

Why is it Important?

• It allows the public to raise objections before the grant.

Importance of Patent Publication

Public Awareness: Allows the public, researchers, and competitors to learn about the invention.

Prevents Duplicate Patents: Helps patent examiners check for similar inventions.

Facilitates Opposition: Third parties can file pre-grant oppositions if they find the invention non-patentable.

Gives Rights to Applicant: After publication, the applicant gets provisional patent rights to seek damages in case of infringement.

Early Publication of Patent (Form 9)

If an applicant does not want to wait for 18 months, they can request early publication by filing Form 9.

Benefits of Early Publication:

• Speeds up the patent examination process.
• Helps secure provisional protection against infringement sooner.

Timeframe for Early Publication:

• The Indian Patent Office publishes the application within one month of receiving Form 9.

When is Early Publication Not Allowed?

• If the invention is against national security or public interest (e.g., defense technologies).

A published patent application contains the following details:

Effect of Publication – Provisional Rights

Once a patent application is published:

The inventor gets provisional rights to claim damages for any infringement that occurs after publication.

However, the inventor can only enforce rights after the patent is granted.

Competitors and the public can review the application and file a pre-grant opposition (Form 7A).

How to Check the Status of a Published Patent?

You can check the publication status of a patent application on:

Indian Patent Office Website: ipindia.gov.in

Google Patents: patents.google.com

WIPO Patentscope: wipo.int

The publication of a patent application is an essential step that ensures transparency, legal protection, and public awareness. Early publication can provide faster legal rights to the inventor, while public opposition ensures only genuine innovations receive patent protection.

Step 5

Request for Examination (RFE)

The Request for Examination (RFE) is a crucial step in the patent registration process under the Indian Patents Act, 1970. Without filing an RFE, the Indian Patent Office will not examine your patent application — regardless of whether it has been published.

What is Request for Examination (RFE)?

A Request for Examination is a formal request submitted by the applicant (or an authorized agent) asking the Indian Patent Office to begin examining the patent application to determine whether it meets the legal requirements for grant.

This examination includes a review of:

• Novelty
• Inventive step (non-obviousness)
• Industrial applicability
• Compliance with Sections 3 and 4 (non-patentable subject matter)

Timeline to File RFE

• RFE must be filed within 48 months from:
  • The date of filing of the patent application or
  • The priority date, whichever is earlier.

Failure to file RFE within this time leads to abandonment of the application.

Form and Fee

• Form 18: Used to file a standard Request for Examination.
• Form 18A: Used for Expedited Examination (available for startups, MSMEs, and international applicants under the PPH – Patent Prosecution Highway).

Fee (as per the latest schedule):

• ₹4,000 (Individuals)
• ₹10,000 (Small entity)
• ₹20,000 (Other entities)

Expedited Examination has higher fees.

Examination Procedure After Filing RFE

1. The application is queued for examination by the Controller of Patents.
2. A First Examination Report (FER) is issued — this includes objections or clarifications required.
3. Applicant must respond to the FER within 6 months (extendable by 3 months).
4. If all objections are resolved, the application proceeds to grant.
5. If not resolved, the application may be rejected.

Expedited Examination (Form 18A)

You can apply for expedited examination under specific categories:

• Startup, MSME
• Female applicants
• Government-supported institutions
• Applicants who chose India as the ISA/IPEA in PCT
• Applicants eligible under PPH (e.g., Japan-India)

Time saved: Grants are typically faster under this route (as early as 12–18 months vs. several years under ordinary process).

Summary

Step 6

Patent Examination

Once a Request for Examination (RFE) is filed (Form 18 or 18A), the Indian Patent Office initiates the Patent Examination process. This is one of the most critical phases in the journey of a patent application, where the invention is scrutinized to determine whether it meets the legal and technical requirements for grant.

What is Patent Examination?

Patent examination is a thorough review conducted by a Patent Examiner from the Indian Patent Office to determine if the invention:

Is novel (new),

Has an inventive step (non-obvious),

Is industrially applicable (useful),

Falls outside non-patentable subject matter (as per Sections 3 and 4 of the Patents Act, 1970),

Complies with formal and technical requirements.

Stages of Patent Examination

1. Allocation to Examiner

Once the RFE is filed, the application is queued and assigned to a Patent Examiner.

The examination is done based on the technical field of the invention.

2. Search for Prior Art

The Examiner conducts a prior art search (existing knowledge or inventions) using global patent databases, scientific publications, etc.

The goal is to check novelty and inventive step.

3. Issuance of First Examination Report (FER)

If the Examiner finds objections or issues, a First Examination Report (FER) is issued to the applicant.

The FER includes:

• Defects in form
• Lack of novelty or inventive step
• Non-patentable subject matter
• Claim clarity or sufficiency of disclosure issues

4. Response to FER

The applicant must respond to the FER within 6 months (extendable by 3 more months).

The response includes:

• Amendments to claims (if required)
• Justifications or arguments against objections

5. Hearing (if required)

If objections persist, a hearing may be scheduled by the Controller.

The applicant presents their case to prove patentability.

6. Final Decision

Based on the response (and hearing, if any), the Controller:

Grants the patent, or

Rejects the application

    Timeline

• The complete examination process may take 1 to 3 years under ordinary examination.
• Expedited examination (Form 18A) may lead to a grant within 12–18 months.
• The patent application is examined for novelty, inventive step, industrial applicability, and compliance with the Act.
• The First Examination Report (FER) is issued with objections, if any.
• The applicant must respond to objections within 6 months (extendable by 3 months).

Step 7

Pre-Grant Opposition (Optional)

Pre-grant opposition is a legal mechanism under the Indian Patents Act, 1970 that allows any person to challenge a patent application before it is granted. It helps maintain the integrity of the patent system by preventing the grant of patents that do not meet the necessary criteria.

What is Pre-Grant Opposition?

• A pre-grant opposition is a formal objection filed after the patent application is published but before the patent is granted.
• It is governed by Section 25(1) of the Patents Act, 1970.
• Any person (individual, company, or organization) can file it, not necessarily an interested party.

When Can It Be Filed?

• After the publication of the patent application (i.e., 18 months after the filing or earlier if early publication is requested).
• Before the grant of the patent.

Grounds for Pre-Grant Opposition (Section 25(1))

An opposition can be filed on one or more of the following 11 grounds:

1. Wrongful obtaining of the invention.
2. Prior publication (the invention was already published in India or abroad).
3. Prior claiming (the same invention was already claimed in another application).
4. Public knowledge or use before the filing date.
5. Obviousness or lack of inventive step.
6. Non-patentable subject matter under Sections 3 and 4.
7. Lack of disclosure or unclear description of the invention.
8. Non-disclosure of source/origin of biological material used.
9. Anticipation by traditional knowledge.
10. Incomplete or wrong information under Section 8 (regarding foreign filings).
11. Non-compliance with statutory requirements.

Procedure for Pre-Grant Opposition

1. Filing Opposition Statement:
   1. File Form 7A with detailed statements and evidence supporting the opposition.
   1. No fee is required for pre-grant opposition.
2. Forwarding to Applicant:
   1. The Controller sends a copy of the opposition to the patent applicant.
3. Reply by Applicant:
   1. The applicant must file a reply and supporting documents within the stipulated time.
4. Hearing:
   1. If required, the Controller may call for a hearing between the parties.
5. Decision:
   1. The Controller may reject the application or allow it to proceed to grant, based on merit.

Key Features

Why is Pre-Grant Opposition Important?

• Prevents frivolous or undeserving patents.
• Protects public interest and access to technology.
• Ensures compliance with patentability criteria.
• Useful in sectors like pharmaceuticals, biotechnology, and traditional knowledge, where unjust patents can have significant impact.

Example: Novartis v. Union of India (2013)

The cancer drug Glivec was opposed under Section 3(d) in a pre-grant and post-grant opposition. Eventually, the Supreme Court denied the patent, citing lack of therapeutic efficacy and attempted “evergreening.”

Step 8

Grant of Patent

The grant of a patent is the final and most crucial stage in the patenting process. Once a patent application has successfully passed examination and cleared any oppositions, the Indian Patent Office officially grants the patent to the applicant, giving them exclusive legal rights over their invention.

Legal Provision

• The grant of a patent is governed by Section 43 of the Indian Patents Act, 1970.
• It states that if the application meets all the conditions under the Act, the patent shall be granted and entered in the Patent Register.

When Is a Patent Granted?

A patent is granted after the following conditions are fulfilled:

1. Request for Examination (RFE) has been filed and examined.
2. All objections (if any) raised in the First Examination Report (FER) are resolved.
3. No pre-grant opposition is pending, or if filed, is resolved in favor of the applicant.
4. The invention is found to be novel, non-obvious, and industrially applicable.

Steps Leading to Grant

What Happens Upon Grant?

1. Patent Certificate Issued:
   The Indian Patent Office issues an official certificate of grant to the applicant.
2. Publication in Patent Journal:
   The grant is published in the Official Patent Journal, and the status of the application changes to “Granted”.
3. Patent Number Assigned:
   The application receives a unique patent number.
4. Patent Term Begins:
   The term of the patent begins from the date of filing (not the grant date) and is valid for 20 years (subject to renewal).

Rights Conferred Upon Grant

Once granted, the patentee has:

• Exclusive rights to make, use, sell, or license the invention.
• The right to sue for infringement in case of unauthorized use.
• The ability to commercialize or assign the patent.

Step 9

Post-Grant Compliance

Once a patent is granted in India, the journey doesn’t end there. The patentee (the person or entity who owns the patent) must comply with certain post-grant legal obligations to maintain and enforce their rights. These are known as Post-Grant Compliance Requirements.

Legal Framework

These obligations are mainly governed by:

• The Patents Act, 1970
• The Patents Rules, 2003 (amended from time to time)

Key Post-Grant Compliance Requirements

1. Renewal of Patent (Maintenance Fees)

• What? Patents are valid for 20 years from the filing date, but renewal fees must be paid annually starting from the 3rd year.
• When? Due before the expiration of the second year (for the 3rd year) and so on.
• Late Fee? A 6-month grace period is allowed with a late fee.
• Form Required: Form 4

2. Working of Patent (Form 27)

• Why? To ensure the patent is being worked (used/commercialized) in India.
• When? Every financial year, to be submitted by September 30 of the next year.
• Form: Form 27
• Details Needed:
  • Whether the invention was worked in India.
  • Revenue/royalties generated.
  • Licensing details.

Non-compliance may attract penalties or even compulsory licensing.

3. Recordal of Assignment or License

• If the patent is assigned, sold, or licensed, the change must be recorded.
• Use Form 16 for assignments.
• Must be done within a reasonable time.
• Helps third parties know who legally owns or uses the patent.

4. Post-Grant Opposition (Section 25(2))

• Can be filed by an interested party within 12 months from the publication of the grant.
• Grounds are similar to pre-grant opposition (e.g., lack of novelty, obviousness, etc.).
• The Opposition Board examines and recommends, and the Controller makes the final decision.

5. Patent Infringement Litigation

          Once granted:

• The patentee has the exclusive right to prevent others from making, using, selling, or importing the patented invention.
• They can file civil suits for infringement in District Courts or High Courts.
• Remedies may include injunctions, damages, or account of profits.

6. Patent of Addition

• If an improvement or modification of an already granted patent is invented, a patent of addition can be filed.
• No renewal fee is required separately.
• Valid as long as the main patent is valid.

Consequences of Non-Compliance

• Lapse of Patent: Failure to pay renewal fees = patent lapses.
• Compulsory Licensing: If patent not worked, a third party may seek a license.
• Legal Disadvantage: Infringement suits may weaken if Form 27 is not filed.

Summary

 
Evolution of Product and Process Patents in India
Pre-1995: Process Patent Regime
Under the Patents Act, 1970, India only granted process patents for pharmaceuticals, chemicals, and food products.
This allowed Indian generic companies to legally manufacture and sell drugs using alternative processes.
Post-1995: Shift to Product Patents (TRIPS Agreement)
India joined the World Trade Organization (WTO) in 1995 and had to comply with the TRIPS Agreement.
TRIPS mandated product patents for pharmaceuticals and agrochemicals.
India amended its patent law through the Patents (Amendment) Act, 2005, allowing product patents in all fields.
Impact of Product Patent Introduction in India
Positive Impacts:
Encouraged foreign investment in R&D. Strengthened IP protection in sectors like biotechnology and pharma.
Boosted innovation in new drug development.
Negative Impacts:
Increased drug prices, as Indian companies could no longer produce cheap generics. Pharmaceutical monopolies emerged, limiting access to medicines.
 
Case Study: Novartis v. Union of India (2013)
Facts: Novartis applied for a product patent for Glivec (cancer drug) in India.
Issue: Indian law (Section 3(d) of the Patents Act) prevents patents for minor modifications of known drugs.
Verdict: The Supreme Court rejected Novartis’ patent, ruling that the new drug was not significantly different from the existing version.
Impact: Strengthened India’s stance on preventing evergreening of patents (minor modifications to extend patent life).
India has evolved from a process patent system to a product patent system, aligning with global standards. While product patents promote innovation, they also increase drug costs. The balance between innovation and affordability remains a key challenge in Indian patent law.

 
Patentability is determined by novelty, inventive step, and industrial applicability. However, certain categories are excluded, ensuring that patents do not unfairly restrict common knowledge or natural discoveries.

Patents are classified based on various factors, such as their nature, subject matter, and purpose. The classification helps in organizing and efficiently examining patent applications.

1. Classification Based on Subject Matter

1.1 Product Patents

• A product patent is granted for an invention of a new product.
• Protects the physical product, preventing others from manufacturing or selling it.

Example:
A new pharmaceutical drug (e.g., a COVID-19 vaccine formula).
A new type of smartphone chip.

Significance:
Strongest form of protection, as it prevents others from making identical products.
Encourages investment in R&D and new product development.

1.2 Process Patents

• A process patent is granted for an innovative manufacturing process or method of production.
• Protects the way a product is made, not the product itself.

Example:
A new method of manufacturing steel to make it more durable.
A new technique for producing insulin in bulk.

Significance:
Companies can develop cheaper manufacturing techniques without copying a patented product.
Common in pharmaceutical, chemical, and industrial sectors.

2. Classification Based on Functionality

2.1 Utility Patents

• Covers new inventions with practical applications.
• Protects how an invention works.

Example:
A new car engine technology that improves fuel efficiency.
A new AI-based voice assistant.

Significance:
The most common type of patent in India.
Encourages technological advancements and industrial growth.

2.2 Design Patents

• Protects the aesthetic or ornamental design of a product.
• Does not protect the functionality of the invention.

Example:
The unique shape of a Coca-Cola bottle.
The design of an Apple MacBook.

Significance:
Important for fashion, consumer goods, and automotive industries.
Prevents counterfeiting of visually unique products.

3. Classification Based on International Patent System

3.1 Conventional Patents

• Filed under India’s domestic patent law.
• Only protects the invention within India.

Significance:
Suitable for small businesses and startups that only operate in India.

3.2 International Patents (PCT Applications)

• Filed under the Patent Cooperation Treaty (PCT).
• Allows patent protection in multiple countries with a single application.

Example:
A pharmaceutical company filing for a patent in India, the US, and Europe simultaneously.

Significance:
Helps companies expand globally.
Protects intellectual property in multiple markets.

4. Classification Based on Industry-Specific Applications

4.1 Biotech Patents

• Protects new genes, microorganisms, genetic modifications, and biotech processes.

Example:
A genetically modified crop resistant to pests.
A new vaccine formula.

Significance:
Important for pharmaceutical and agriculture industries.
Subject to strict patentability criteria in India.

4.2 Software and AI Patents

• India does not grant patents for software alone, but software combined with hardware may be patentable.

Example:
An AI-driven medical imaging system.
A new encryption algorithm embedded in a security device.

Significance:
Crucial for IT and artificial intelligence sectors.
Still an evolving area in Indian patent law.

4.3 Green Technology Patents

• Protects eco-friendly and sustainable innovations.

Example:
A new solar panel material with higher efficiency.
A biodegradable alternative to plastic.

Significance:
Supports India’s commitment to climate change and sustainability.
Attracts government incentives and global funding.

India’s patent classification system helps in organizing and protecting different types of innovations. Whether it’s a pharmaceutical drug, an AI-driven invention, or an eco-friendly technology, patents ensure exclusive rights to inventors while promoting economic and technological growth.

Need for a New Patent Law
Issues with the colonial patent system
The Indian Patents & Designs Act, 1911 favored foreign companies.
Over 80% of patents were held by foreign entities, especially in pharmaceuticals and chemicals.
High drug prices due to foreign monopolies.
No strong provisions for compulsory licensing or domestic industry growth.
Growing Demand for Change
India’s leaders, including Jawaharlal Nehru, emphasized self-reliance in science and technology.
Indian scientists, industrialists, and policymakers demanded patent laws that encouraged local innovation.
The government sought to reduce dependency on foreign pharmaceutical companies and promote affordable medicine.
The Justice N. Rajagopala Ayyangar Committee (1957-1959)
In 1957, the Indian government formed a committee under Justice N. Rajagopala Ayyangar to review the patent system.
His report (1959) was one of the most important documents in India’s patent law history.
The committee recommended major reforms, including:
India should abolish product patents for food, medicines, and chemicals to prevent foreign monopolies.
Only process patents should be granted for pharmaceuticals and chemicals, allowing Indian companies to develop alternative production methods.
Strengthen compulsory licensing to ensure access to essential goods.
Reduce patent terms to 14 years (instead of 16 years under the 1911 Act).
Establish a stronger patent administration system.

The Patents Act, 1970: A Landmark Legislation
Based on Ayyangar’s recommendations, India passed The Patents Act, 1970, which completely overhauled the patent system.
Major Features of the Patents Act, 1970
Abolition of Product Patents in Pharmaceuticals & Agrochemicals
To prevent foreign companies from monopolizing essential drugs and chemicals.
Allowed Indian pharmaceutical companies to manufacture cheaper generic versions.
Introduction of Process Patents
Only process patents were granted in the food, drug, and chemical sectors.
This allowed Indian manufacturers to create the same product using a different process.
Shortened Patent Term
14 years for most patents.
7 years for food, drugs, and chemical patents.
Strong Compulsory Licensing Provisions
The government could force a patent holder to license their patent if:
The invention was not being used in India.
The price was too high.
Public interest was affected.
Encouraging Domestic Innovation
The law favored Indian companies, helping them become self-reliant.
Led to rapid growth in India’s pharmaceutical industry.

Impact of the Patents Act, 1970
Growth of India’s Pharmaceutical Industry
Before 1970, India imported most of its medicines.
After 1970, Indian companies like Ranbaxy, Cipla, and Dr. Reddy’s started manufacturing affordable medicines.
India became a global leader in generic drugs.
Reduction in Drug Prices
Foreign companies could no longer control drug prices with patents.
Essential medicines became cheaper and more accessible.
Boost to Indigenous Innovation
Indian scientists and researchers started focusing on alternative drug formulations.
Local industries grew in agriculture, chemicals, and engineering.
 
The TRIPS Agreement and Patent Reforms (1995 – 2005)
The period from 1995 to 2005 was a transformational phase in India’s patent law, driven by its commitments under the World Trade Organization (WTO). India was required to align its patent laws with the global intellectual property framework, particularly the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS).
This era saw major amendments to the Patents Act, 1970, reintroducing product patents, extending patent terms, and modernizing India’s intellectual property regime.
India’s Entry into the WTO and TRIPS (1995)
What is TRIPS?
TRIPS (Trade-Related Aspects of Intellectual Property Rights) is an international agreement under the WTO (World Trade Organization).
It sets minimum standards for intellectual property rights (IPR), including patents, trademarks, and copyrights.
It required all WTO members (including India) to comply with uniform patent protection laws.
India’s Obligations under TRIPS
India joined the WTO in 1995, making it bound to comply with TRIPS provisions.
Under TRIPS Article 27, India had to:
Allow product patents in all fields of technology, including pharmaceuticals and agriculture.
Grant patents for at least 20 years.
Strengthen patent enforcement mechanisms.
India was given a 10-year transition period (1995–2005) to gradually implement these changes.
Key Amendments to Indian Patent Law (1995 – 2005)
To comply with TRIPS, India made three key amendments to the Patents Act, 1970:
The Patents (Amendment) Act, 1999
Introduced the mailbox system:
Allowed applicants to file patent applications for pharmaceutical and agricultural products, even though product patents were not yet granted.
Introduced Exclusive Marketing Rights (EMRs):
Provided a temporary monopoly (up to 5 years) for drug companies before a full patent system was implemented.
The Patents (Amendment) Act, 2002
Extended the patent term from 14 years to 20 years (for all patents).
Introduced compulsory licensing provisions under TRIPS, allowing India to grant licenses for life-saving drugs in cases of public health emergencies.
Strengthened patent examination procedures.
The Patents (Amendment) Act, 2005
Reintroduced product patents in pharmaceuticals, food, and chemicals, fully complying with TRIPS.
Abolished the EMR system (as product patents were now available).
Strengthened opposition and revocation mechanisms for patents to prevent misuse.
Introduced Section 3(d) – A critical provision that:
Prevented “evergreening” of patents (companies making minor modifications to extend patent life).
Allowed patents only for truly new and innovative drugs.
Led to landmark legal battles like Novartis v. Union of India (2013).
Impact of the TRIPS-Compliant Patent Reforms
Positive Impact
Boosted Foreign Investment:
The stronger patent regime encouraged global pharmaceutical and technology companies to invest in India.
Encouraged Domestic Innovation:
Indian companies increased R&D investments to develop new drugs and technologies.
Strengthened India’s Position in Global Trade:
Compliance with WTO-TRIPS improved India’s credibility in international markets.
Concerns and Challenges
Higher Drug Prices:
Introduction of product patents meant that multinational drug companies could charge higher prices for patented medicines.
Impact on the Generic Drug Industry:
Indian pharmaceutical companies, which thrived under the process patent system, now had to compete with global giants.
Legal Battles Over Section 3(d):
The pharmaceutical industry saw intense litigation, particularly regarding evergreening of patents.
The Supreme Court ruling in Novartis v. Union of India (2013) upheld Section 3(d), ensuring affordable medicines for the public.
 
Key Amendments to the Patents Act Post-2005
After 2005, India continued refining its patent laws to address technological advancements, global trade requirements, and national interests. Several amendments and policy updates were introduced to streamline the patent process, support innovation, and maintain affordability of essential goods, particularly medicines.
 
The Patents (Amendment) Rules, 2006
Improve patent application and opposition procedures.
Key Changes:
Introduced pre-grant opposition (any person can challenge a pending patent).
Strengthened post-grant opposition mechanisms (patents can be challenged within 1 year of grant).
Required more detailed patent specifications.
Impact:
Increased transparency in patent granting.
Empowered competitors and public health advocates to challenge unfair patents.

The Patents (Amendment) Rules, 2012
Support pharmaceutical and biotech industries while ensuring affordable medicines.
Key Changes:
Allowed compulsory licensing (first issued to Natco Pharma for Bayer’s cancer drug Nexavar in 2012).
Strengthened Section 3(d) (to prevent evergreening of pharmaceutical patents).
Impact:
Ensured low-cost generic drugs were available to the public.
Encouraged domestic pharma companies to compete globally.
 
The Patents (Amendment) Rules, 2016
Objective:
Speed up patent applications and encourage startups & MSMEs.
Key Changes:
Fast-track examination for startups, MSMEs, and women inventors.
Reduced patent filing fees for startups and small companies.
E-filing and digital processes introduced.
Impact:
Helped startups file patents faster.
Boosted India’s innovation ecosystem.
 
The Patents (Amendment) Rules, 2019
Make patent filing more affordable and accessible.
Key Changes:
Reduced patent fees for educational institutions.
Allowed expedited examination for government and PCT (Patent Cooperation Treaty) applicants.
 Impact:
Encouraged universities to patent more research.
Strengthened India’s participation in global patent frameworks.
 
The Patents (Amendment) Rules, 2021
Improve India’s Ease of Doing Business ranking by simplifying patent laws.
Key Changes:
Further reduced fees for MSMEs, startups, and academic institutions.
Allowed pre-grant oppositions to be processed faster.
Increased transparency in patent licensing & working statements.
Impact:
Made India’s patent system more efficient.
Encouraged more patent filings from Indian startups and universities.
 
Recent Policy Updates and Future Trends
 National IPR Policy, 2016
Launched by DIPP (Department for Promotion of Industry and Internal Trade).
Aims to strengthen India’s IPR ecosystem and increase awareness about patent rights.
Artificial Intelligence (AI) & Software Patents
AI and software-related patents remain a grey area.
India does not grant software patents easily, unlike the US and Europe.
Compulsory Licensing & Public Health Exceptions
India continues to grant compulsory licenses for essential drugs.
Future amendments may focus on balancing patent rights with public health needs.
 

A patent is a legal right granted by the Government to an inventor for a new and useful invention giving them control over its making, using, selling and distributing. It provides exclusive rights to make, use, sell, or distribute the invention for a specific period, usually 20 years from the date of filing. In exchange, the inventor must publicly disclose the details of the invention, allowing others to learn from it after the patent expires.

Patents fall under Intellectual Property (IP) Law, which protects innovations and encourages technological advancements by rewarding inventors for their creativity and investment.

A patent can be granted for:

• A new product (e.g., a new type of smartphone battery).
• A new process (e.g., a unique method to manufacture vaccines).
• A combination of known technologies that results in a novel and useful outcome.

Features of a Patent

• Exclusive Rights: The inventor gets a monopoly over the invention.
• Limited Duration: Protection lasts for 20 years from the filing date.
• Public Disclosure: The invention must be published in the patent database.
• Territorial Rights: A patent is valid only in the country where it is granted.

Importance of Patents in India

India, as a rapidly developing country, relies on innovation and technology to drive economic growth. Patents encourage research and development (R&D) and ensure that inventors benefit from their inventions.

Encourages Innovation and R&D: Patents give inventors a financial incentive by granting exclusive rights to commercialize their innovations. This fosters an environment where companies and individuals invest in new technology, pharmaceuticals, and industrial processes.

Protects Inventors’ Rights: Without patent protection, inventors could lose their innovations to competitors who copy their ideas. Patents ensure that inventors get the credit and profits from their hard work.

Attracts Foreign Investments: A strong patent system encourages foreign companies to invest in India because they know their innovations will be protected. This is particularly important in industries like biotechnology, artificial intelligence, and pharmaceuticals.

Boosts Economic Growth: Patents promote industrialization by encouraging startups and businesses to develop unique products. This helps increase employment and contributes to India’s GDP growth.

Enhances Competitiveness in Global Markets: Countries with strong patent laws become global leaders in innovation. India’s growing patent system helps Indian companies compete internationally, especially in pharmaceuticals, IT, and engineering.

Purpose of Patents in India

The patent system is designed to balance the rights of inventors and the welfare of society. The main objectives of the patent system in India include:

Protecting and Rewarding Innovation: The fundamental purpose of patents is to protect new inventions and provide inventors with an exclusive right over their work. This encourages individuals and companies to invest in research and development (R&D).

Promoting Public Disclosure of Knowledge: In return for granting patent rights, inventors must disclose the technical details of their inventions. This allows other researchers and businesses to learn from these inventions and improve upon them.

Preventing Unauthorized Use and Imitation: Patents prevent others from copying or selling an invention without the inventor’s permission. This legal protection ensures that companies benefit from their investment in innovation.

Supporting Public Interest & Affordable Technology: The Indian patent system has provisions (such as compulsory licensing) to ensure that patents do not create monopolies that harm public welfare. For example, life-saving drugs can be produced by other manufacturers at lower prices under certain conditions.

Strengthening India’s Position in Global Trade: As India participates in international trade agreements, having a strong patent system aligns Indian businesses with global intellectual property laws, allowing them to export patented products and technologies.